A study of loculated tuberculous pleural effusions treated with intrapleural urokinase.

Abstract:

AIM:To assess the effect of intrapleural urokinase, vis-à-vis simple pleural drainage, on residual pleural thickening in a series of patients suffering from loculated tuberculous pleural effusion. PATIENTS AND METHOD:Twenty-nine patients (21 males and 8 females) with loculated pleural effusion were studied. These patients were randomly allocated to one of two groups: one group received intrapleural urokinase (n=12) and the other was treated by simple drainage with suction (n=17). The urokinase (125,000 UI) was administered into the pleural cavity via an intrathoracic tube. This procedure was repeated every 12h until the quantity of pleural fluid obtained was less than 50 cm3, at which point the intrathoracic tube was removed. RESULTS:In both groups, the biochemical analysis of the pleural fluid was an exudate and the fluid had a serous appearance. Pleural thickening when the drainage tube was removed was 8.09+/-3.36 mm for the group treated with urokinase, and 14.78+/-17.20mm (P>0.05) for the control group. Residual pleural thickening measured upon completion of medical treatment at 6 months was 1.45+/-0.89 mm for the group treated with urokinase and 7.47+/-10.95 mm for the control group (P<0.05). In the control group, only two patients presented over 10mm of residual pleural thickening. The mean quantity of fluid drained in the two groups was 1.487+/-711 ml for the patients with urokinase, and 795+/-519 ml for the control group (P<0.01). CONCLUSION:Our study shows that patients with loculated tuberculous pleural effusion treated with urokinase suffered less from residual pleural thickening, as measured after six months, than those treated by simple drainage. It is therefore suggested that the administration of intrapleural urokinase is a safe and effective treatment for those patients who drain a larger quantity of pleural fluid.

journal_name

Respir Med

journal_title

Respiratory medicine

authors

Cases Viedma E,Lorenzo Dus MJ,González-Molina A,Sanchis Aldás JL

doi

10.1016/j.rmed.2006.02.010

subject

Has Abstract

pub_date

2006-11-01 00:00:00

pages

2037-42

issue

11

eissn

0954-6111

issn

1532-3064

pii

S0954-6111(06)00095-3

journal_volume

100

pub_type

杂志文章,随机对照试验
  • Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.

    abstract::The fraction of the emitted dose from an inhaler that has the potential to be deposited into the lungs is known as the fine particle dose (also the respirable dose). During inhalation all dry powder inhalers require a 'force' to be created inside the device so that a fine particle dose is generated from the formulatio...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2003.1351

    authors: Chrystyn H

    更新日期:2003-02-01 00:00:00

  • Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.

    abstract::Turbuhaler has a very high resistance hence patient inhalation flow when using it would be low. The total emitted dose (TED) of 500microg terbutaline sulphate from a Bricanyl Turbuhaler was determined using a range of inhalation flows (10-60L min(-1)) with inhalation volume of 2 and 4L using a DPI sampling apparatus a...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2009.11.014

    authors: Abdelrahim ME

    更新日期:2010-05-01 00:00:00

  • Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients.

    abstract:OBJECTIVE:This study evaluated the tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in patients with COPD. METHODS:This double-blind, placebo-controlled study (NCT00629239) randomised patients with moderate to severe COPD to AZD4818 300mug or placebo twice daily via Turbuhaler((R)) for 4 weeks. Safety,...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2010.04.010

    authors: Kerstjens HA,Bjermer L,Eriksson L,Dahlström K,Vestbo J

    更新日期:2010-09-01 00:00:00

  • Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.

    abstract:BACKGROUND:An Expert Forum was held at the 2014 European Respiratory Society International Congress to address issues involved in the management of Pseudomonas aeruginosa infection in patients with non-cystic fibrosis bronchiectasis (NCFB). Multiple studies have found that chronic P. aeruginosa infection is associated ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2016.06.007

    authors: Wilson R,Aksamit T,Aliberti S,De Soyza A,Elborn JS,Goeminne P,Hill AT,Menendez R,Polverino E

    更新日期:2016-08-01 00:00:00

  • Reassessment of asthma management in an accident and emergency department.

    abstract::To determine if shortcomings in asthma management in the Accident and Emergency (A & E) department identified in a previous (1983) study (Reed et al. Thorax 1985; 40: 897-902) had been corrected, we retrospectively reviewed the case records of patients attending with asthma between December 1987 and November 1988. The...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/s0954-6111(06)80180-0

    authors: Chidley KE,Wood-Baker R,Town GI,Sleet RA,Holgate ST

    更新日期:1991-09-01 00:00:00

  • Cough induced by low pH.

    abstract::Citric acid has been used as a tussive agent in the investigation of the cough reflex. The mechanism of cough stimulation remains unclear. We conducted studies to compare the cough response of citric acid to an organic (acetic acid) and an inorganic acid (phosphoric acid). We also compared the cough response of citric...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0954-6111(99)90078-1

    authors: Wong CH,Matai R,Morice AH

    更新日期:1999-01-01 00:00:00

  • Brief upper airway dysfunction.

    abstract::We have analysed the clinical manifestations of nine patients with brief upper airway dysfunction (BUAD) who attended the thoracic department of a major teaching hospital between 1987 and 1991. Episodes of BUAD developed within 1-4 months of presentation in three patients but were undiagnosed for 2.5-12.5 years in six...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/0954-6111(94)90024-8

    authors: Campbell AH,Pierce R

    更新日期:1994-02-01 00:00:00

  • Cystic fibrosis in children from ethnic minorities in the West Midlands.

    abstract:BACKGROUND:We have observed that Doctors often perceive that cystic fibrosis (CF) is exceptionally rare in non-whites, and that this bias has repeatedly resulted in diagnostic delay. We therefore compared the age at diagnosis, genetic features and relative prevalence of CF in non-whites and white patients in the West M...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/s0954-6111(05)80065-4

    authors: Spencer DA,Venkataraman M,Higgins S,Stevenson K,Weller PH

    更新日期:1994-10-01 00:00:00

  • Population-based estimates of transbronchial lung biopsy utilization and complications.

    abstract:BACKGROUND:Little is known about trends in the utilization or complication rates of transbronchial lung biopsy, particularly in community hospitals. METHODS:We used the Healthcare Cost and Utilization Project Florida State Inpatient and State Ambulatory Surgical Databases to assess trends in transbronchial lung biopsy...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2012.08.008

    authors: Tukey MH,Wiener RS

    更新日期:2012-11-01 00:00:00

  • Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-naïve sarcoidosis patients.

    abstract::Invariant natural killer T (NKT) cells might contribute to the amplified and prolonged T-cell immune response that characterizes sarcoidosis. Therefore, we want to investigate the frequency and distribution of pulmonary invariant NKT cells in corticosteroid-naïve patients with sarcoidosis. We used multi-parameter flow...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2009.11.008

    authors: Korosec P,Rijavec M,Silar M,Kern I,Kosnik M,Osolnik K

    更新日期:2010-04-01 00:00:00

  • A retrospective analysis of the pathogens in the airways of patients with primary ciliary dyskinesia.

    abstract:INTRODUCTION:Primary ciliary dyskinesia (PCD) is a rare genetically heterogeneous disorder of motile cilia, which leads to recurrent and chronic airway infections. Detailed information about infection causing pathogens is scarce. With this study, we aimed to determine the prevalence and susceptibility of the most commo...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2019.08.009

    authors: Roden L,Görlich D,Omran H,Peters G,Große-Onnebrink J,Kahl BC

    更新日期:2019-09-01 00:00:00

  • Persistence with inhaled corticosteroid therapy in daily practice.

    abstract:OBJECTIVE:To quantify persistence with inhaled corticosteroids (ICS) among new users in daily practice and identify determinants of persistence. METHODS:A retrospective cohort study was performed with data from the Dutch PHARMO system. This system consists of medication and hospital admission records of 325,000 inhabi...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2004.01.014

    authors: Breekveldt-Postma NS,Gerrits CM,Lammers JW,Raaijmakers JA,Herings RM

    更新日期:2004-08-01 00:00:00

  • Three-year follow-up study of allergy in workers in a mushroom factory.

    abstract::Exposure to mushroom spores may cause many respiratory allergic diseases, however, there has been no serial study in a mushroom factory to address this problem. The aim of this study was to investigate the serial changes in respiratory allergy and the incidence of hypersensitivity pneumonitis (HP) in mushroom workers....

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2001.1187

    authors: Tanaka H,Saikai T,Sugawara H,Tsunematsu K,Takeya I,Koba H,Matsuura A,Imai K,Abe S

    更新日期:2001-12-01 00:00:00

  • Concurrent presentations of the sarcoidosis, tuberculosis and lymphoma in a single patient.

    abstract::A 56-year-old female patient, developing ALK-negative anaplastic T cell lymphoma 7 years after the diagnosis of sarcoidosis with clinical and histopathological features of tuberculosis has been presented. We herein present concurrent occurrence of the sarcoidosis, lymphoma and tuberculosis along with the confusing fin...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2005.09.001

    authors: Tufan A,Ranci O,Sungur A,Topeli A,Haznedaroglu I,Cöplü L

    更新日期:2006-05-01 00:00:00

  • Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.

    abstract::The aim of this study was evaluate the predictive value of a 2 week course of prednisolone on the effect of 6 months treatment with inhaled budesonide in patients with stable chronic obstructive pulmonary disease (COPD). Forty patients with stable COPD entered the study, and received prednisolone (37.5 mg o.d.) for 2 ...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0954-6111(99)90038-0

    authors: Senderovitz T,Vestbo J,Frandsen J,Maltbaek N,Nørgaard M,Nielsen C,Kampmann JP

    更新日期:1999-10-01 00:00:00

  • T-cell activation by organic dust in vitro.

    abstract::Inhalation of swine dust causes intense airway inflammation with a multifold increase of inflammatory cells and lymphocyte activation as assessed by bronchoalveolar lavage. To further investigate the mechanism for lymphocyte activation the present in vitro study focuses on the lymphocyte response to swine dust in whol...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2000.0828

    authors: Müller-Suur C,Larsson PH,Larsson K

    更新日期:2000-08-01 00:00:00

  • Multinational cohort study of mortality in patients with asthma and severe asthma.

    abstract:BACKGROUND:Data on the risk of death following an asthma exacerbation are scarce. With this multinational cohort study, we assessed all-cause mortality rates, mortality rates following an exacerbation, and patient characteristics associated with all-cause mortality in asthma. METHODS:Asthma patients aged ≥18 years and...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2020.105919

    authors: Engelkes M,de Ridder MA,Svensson E,Berencsi K,Prieto-Alhambra D,Lapi F,Giaquinto C,Picelli G,Boudiaf N,Albers FC,Cockle SM,Bradford ES,Suruki RY,Brusselle GG,Rijnbeek PR,Sturkenboom MC,Verhamme KM

    更新日期:2020-01-01 00:00:00

  • The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns.

    abstract::Idiopathic pulmonary fibrosis is the most common of the idiopathic interstitial lung diseases referring to the histo-pathological entity of usual interstitial pneumonia. It has been hypothesized that inflammation may trigger the multiformic fibrotic lesions found in the affected lung, and defects in the innate immune ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2004.08.003

    authors: Hodgson U,Tukiainen P,Laitinen T

    更新日期:2005-03-01 00:00:00

  • Prophylactic use of noninvasive ventilation in patients undergoing lung resectional surgery.

    abstract:QUESTION OF THE STUDY:We studied whether prophylactic use of noninvasive pressure support ventilation (NIPSV) administered pre- and postoperatively may reduce the postoperative pulmonary function impairment. PATIENTS AND METHODS:Prospective randomized clinical trial. Thirty-nine patients with a preoperative FEV(1) <70...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2006.12.002

    authors: Perrin C,Jullien V,Vénissac N,Berthier F,Padovani B,Guillot F,Coussement A,Mouroux J

    更新日期:2007-07-01 00:00:00

  • A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.

    abstract:OBJECTIVE:To compare the effects of once-daily ciclesonide and twice-daily fluticasone propionate in patients with moderate persistent asthma. METHODS:Patients aged 12-75 years with moderate bronchial asthma entered a 1-4 week run-in period. For inclusion into the 12-week, randomized, open-label treatment period, pati...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2007.03.001

    authors: Boulet LP,Bateman ED,Voves R,Müller T,Wolf S,Engelstätter R

    更新日期:2007-08-01 00:00:00

  • Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis.

    abstract::Recombinant human DNase I (rhDNase) has been shown to improve pulmonary function in patients treated for up to 6 months. A cohort of 52 cystic fibrosis patients with a FVC > 40% predicted were enrolled into an open label study in order to evaluate longer-term effects of rhDNase. They received 2.5 mg rhDNase twice dail...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/0954-6111(95)90126-4

    authors: Shah PL,Scott SF,Geddes DM,Hodson ME

    更新日期:1995-08-01 00:00:00

  • Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis.

    abstract:BACKGROUND:The ability to exercise is an important clinical outcome in COPD, and the improvement in exercise capacity is recognized to be an important goal in the management of COPD. Therefore, since the current interest in the use of bronchodilators in COPD is gradually shifting towards the dual bronchodilation, we ca...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.rmed.2017.06.020

    authors: Calzetta L,Ora J,Cavalli F,Rogliani P,O'Donnell DE,Cazzola M

    更新日期:2017-08-01 00:00:00

  • Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

    abstract:OBJECTIVES:To determine the efficacy of oral theophylline compared with placebo in people with stable chronic obstructive pulmonary disease (COPD). METHODS:Systematic review of randomized-controlled trials comparing oral theophylline with placebo for a minimum of 7 days in people with stable COPD. RESULTS:Twenty rand...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.rmed.2004.10.009

    authors: Ram FS,Jardin JR,Atallah A,Castro AA,Mazzini R,Goldstein R,Lacasse Y,Cendon S

    更新日期:2005-02-01 00:00:00

  • Managing malnutrition in COPD: A review.

    abstract::In the UK approximately 1.2 million people have COPD with around 25-40% being underweight and 35% have a severely low fat-free mass index. Measuring their body mass index is recommended and Health care professionals should endeavour to ensure that COPD patients are achieving their nutritional requirements. A narrative...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2020.106248

    authors: Keogh E,Mark Williams E

    更新日期:2020-11-21 00:00:00

  • Effects of allergen exposure on methacholine and AMP-induced air trapping in pollen-sensitive subjects.

    abstract:BACKGROUND:The effect of pro-inflammatory stimuli on bronchoconstrictor-induced air trapping has not been studied. OBJECTIVE:To determine the effect of natural allergen exposure, a pro-inflammatory stimulus, on methacholine- and adenosine 5'-monophospate (AMP)-induced air trapping. METHODS:Airway responsiveness to me...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2010.11.023

    authors: Lopez V,Prieto L,Perez C,Barato D,Marin J

    更新日期:2011-06-01 00:00:00

  • Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease.

    abstract::This retrospective study was designed to evaluate the safety and efficacy of a bronchoprotective sputum induction protocol in moderate to severe chronic obstructive pulmonary disease (COPD). Forty-two adults with COPD (FEV1 = 51.7 +/- 3.2% predicted (mean +/- SEM)) under went sputum induction using a protocol designed...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2002.1342

    authors: Sutherland ER,Pak J,Langmack EL,Silkoff PE,Martin RJ

    更新日期:2002-07-01 00:00:00

  • Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

    abstract:BACKGROUND:The prevalence of chronic obstructive pulmonary disease (COPD) according to guidelines of today seems considerably higher than has been reported also in recent literature. AIM:To estimate the prevalence of COPD as defined by British Thoracic Society (BTS) criteria and the recent global initiative for chroni...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2003.1446

    authors: Lundbäck B,Lindberg A,Lindström M,Rönmark E,Jonsson AC,Jönsson E,Larsson LG,Andersson S,Sandström T,Larsson K,Obstructive Lung Disease in Northern Sweden Studies.

    更新日期:2003-02-01 00:00:00

  • Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study.

    abstract:BACKGROUND:The synergistic interactions between pharmacotherapy and pulmonary rehabilitation has been provided, but it remains to be established whether this may also apply to more severe patients. OBJECTIVES:We have examined whether tiotropium enhances the effects of exercise training in patients with advanced COPD (...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2009.10.005

    authors: Pasqua F,Biscione G,Crigna G,Auciello L,Cazzola M

    更新日期:2010-03-01 00:00:00

  • Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.

    abstract:BACKGROUND:Patients with severe or very severe chronic obstructive pulmonary disease (COPD) frequently suffer repeated exacerbations generating high health care utilization costs. Combined corticosteroid and bronchodilator treatment using a single inhaler might - via improved compliance - reduce exacerbation rates. OB...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2012.12.020

    authors: Hagedorn C,Kässner F,Banik N,Ntampakas P,Fielder K

    更新日期:2013-04-01 00:00:00

  • Aerosol delivery of nebulised budesonide in young children with asthma.

    abstract:BACKGROUND:Lung deposition of inhaled steroids, likely to be of benefit in the anti-inflammatory treatment of asthma in young children, is low. This is explained by age specific anatomical and physiological characteristics as well as poor cooperation with aerosol therapy. However, total lung deposition and the ratio of...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2009.04.029

    authors: Schueepp KG,Devadason SG,Roller C,Minocchieri S,Moeller A,Hamacher J,Wildhaber JH

    更新日期:2009-11-01 00:00:00